CYG
ICPT

Clean Yield Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Clean Yield Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-710
Closed -$14K – 488
2021
Q2 		$14K Buy
+710
New +$14.1K ﹤0.01% 345
2021
Q1 		– Sell
-710
Closed -$18K – 407
2020
Q4 		$18K Buy
+710
New +$23.5K 0.01% 317

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clean Yield Group's ICPT Position: Q3 2021 in Review

Clean Yield Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2021, closing a stake of 710 shares — an estimated $14K sold.

Clean Yield Group first reported a position in ICPT in Q4 2020 and held it in 2 quarters. The position peaked at $18K in Q4 2020. 139 funds tracked by Wall St. Rank hold ICPT as of Q3 2021.

  • Clean Yield Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Clean Yield Group sold 710 Intercept Pharmaceuticals, Inc. shares in Q3 2021, an estimated $14K.
  • Clean Yield Group first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
  • Clean Yield Group's Intercept Pharmaceuticals, Inc. position peaked at $18K in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2021.

Based on Clean Yield Group's 13F filing for Q3 2021, filed 27 Oct 2021.